99% Savings - Buy Just @1 Rs X
Bimaday is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Bimaday safe for pregnant women?
It is not known what effect Bimaday will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Bimaday safe during breastfeeding?
In the absence of any scientific study about the side effects of Bimaday in breastfeeding women, information on safety of Bimaday is unavailable.
What is the effect of Bimaday on the Kidneys?
Bimaday is completely safe for kidneys.
What is the effect of Bimaday on the Liver?
Bimaday is not harmful for the liver.
What is the effect of Bimaday on the Heart?
Bimaday is not harmful for the heart.
Bimaday should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Bimaday unless your doctor advises you to do so -
Is this Bimaday habit forming or addictive?
No, there is no any evidence that Bimaday is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Bimaday does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, Bimaday is safe for use.
Is it able to treat mental disorders?
There is no benefit of taking Bimaday for mental disorders.
Interaction between Food and Bimaday
Taking Bimaday with food does not harm your health.
Interaction between Alcohol and Bimaday
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Bimaday.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 227-228
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 155
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lumigan® (bimatoprost)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Latisse® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bimatoprost Sandoz® (bimatoprost)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lumigan® Pf (bimatoprost)